Clinical trial

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

NCT00433459 · Christine Mauz-Körholz, Other · Completed

Key facts

NCT number NCT00433459
Title Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
Official title First International Inter-Group Study for Classical Hodgkin's Lymphoma in Children and Adolescents
Lead sponsor Christine Mauz-Körholz, Other
Collaborators Deutsche Krebshilfe e.V., Bonn (Germany) Euronet Worldwide
Status Completed
Phase Phase 3
Study type Interventional
Conditions Lymphoma
Intervention type Drug, Radiation
Interventions cyclophosphamide, dacarbazine, prednisolone, prednisone, procarbazine hydrochloride, vincristine sulfate, fludeoxyglucose F 18, radiation therapy
Enrollment 2,134
Start date Jan 1, 2007
Primary completion Jan 1, 2013
Completion Jan 1, 2013
First posted Feb 12, 2007
Last update posted Mar 26, 2020
Countries Germany, United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies